![]() |
市場調查報告書
商品編碼
1729632
日本傷口護理市場規模、佔有率、趨勢及預測(按產品類型、傷口類型、最終用戶和地區),2025 年至 2033 年Japan Wound Care Market Size, Share, Trends and Forecast by Product Type, Wound Type, End User, and Region, 2025-2033 |
2024 年,日本傷口護理市場規模價值 7.4571 億美元。展望未來, IMARC Group估計到 2033 年市場規模將達到 11.2743 億美元,2025 年至 2033 年的複合年成長率為 4.30%。市場的主要促進因素是糖尿病等慢性病的盛行率不斷上升、傷口護理技術的進步、感染控制意識的不斷增強、醫療支出的增加、政府改善醫療基礎設施的舉措以及向微創治療的轉變,這些都促進了市場的強勁成長。
日本市場主要受到糖尿病和肥胖症等生活方式疾病發病率上升的推動,這進一步增加了慢性傷口的發病率,因此對有效的傷口管理解決方案的需求持續增加。日本人口老化主要影響了壓瘡和糖尿病足潰瘍等慢性傷口盛行率的增加,從而增加了對先進傷口護理產品的需求。此外,日本醫療基礎設施的改善以及醫療技術投資的增加使得市場不斷擴大。例如,日本厚生勞動省於2024年8月26日公佈了“全球健康願景2024”,旨在透過創新、公平獲得醫療保健和加強國際合作來應對全球健康挑戰。該策略優先考慮大流行病防範、衛生系統復原力和推動全民健康覆蓋。它加強了日本作為全球衛生領域領導者的地位,服務於聯合國永續發展目標。
此外,醫療保健提供者和患者對先進傷口護理產品比傳統方法具有更好效果的認知不斷提高,進一步擴大了市場滲透率。除此之外,政府發起的旨在提供更好的醫療保健服務的計劃和加強傷口護理產品的報銷政策促進了市場成長。主要產業參與者更加重視研發 (R&D) 活動,從而加快了符合日本民眾需求的新時代產品的推出速度,從而推動了市場的發展。例如,2024 年 3 月 13 日,日本研究人員設計了一種新時代的生物電子傷口敷料,將水凝膠與微電子技術相結合,以促進更快的癒合並最大限度地減少感染的機會。這項創新可以監測傷口環境並提供精確的電刺激,增強組織修復。這項突破凸顯了日本在融合生物技術和電子技術以應對醫療保健挑戰方面的領導地位。
先進傷口護理產品的採用率不斷提高
水凝膠、水膠體和銀基敷料等先進傷口護理產品的普及,支持了日本整體傷口護理市場的成長。 2024 年 6 月發表在《臨床與轉化研究雜誌》上的一項研究調查了一種含有銀奈米顆粒的新型敷料對慢性潰瘍的有效性。這種先進的敷料可以使傷口癒合速度比平常快幾倍,並可以作為傷口慢性管理的新概念帶來有希望的結果。與常見的傷口護理產品相比,此類產品具有更好的保濕性和抗菌作用。因此,由於日本醫療保健提供者希望患者獲得更好的治療效果,對先進傷口護理產品的需求預計會增加。希望盡量減少醫療相關感染並實現快速治愈,這促使人們專注於提供感染控制和組織再生等高級功能的產品。
遠距醫療和數位工具的作用日益增強
日本一直在投資數位健康技術,包括遠距醫療平台、行動健康應用程式和傷口護理監測系統。這些工具使患者能夠接受遠端諮詢,監測傷口癒合過程並獲得及時介入。醫療保健提供者可以透過數位平台有效地管理多名患者,提高護理的可近性和連續性,特別是對於農村地區的患者或行動不便的老年患者。這從整體上改善了患者護理並最佳化了治療結果。例如,2024 年 6 月 4 日,Infosys 和日本最大的配藥連鎖店 Nihon Chouzai 宣布合作,透過尖端的線上藥物增強日本的醫療保健服務。作為合作的一部分,Infosys 設計了 NiCOMS,這是一款行動遠距醫療應用程式,允許患者從註冊藥劑師那裡獲得遠端用藥指導,從而無需他們親自前往藥房。
個人化傷口護理解決方案的興起
個人化傷口護理解決方案的興起,滿足了患者的個人需求,極大地影響了日本傷口護理市場佔有率。隨著生物技術和再生醫學的進步,生物工程皮膚替代品和負壓傷口治療系統等產品越來越受歡迎。例如,2024年4月1日,在日本擁有超過25年經驗的著名醫療器材製造商Smith+Nephew推出了用於家庭慢性傷口護理的RENASYS EDGE負壓傷口治療系統。此緊湊系統的設計旨在為患者提供舒適感和易用性,同時確保有效的治療。透過與 SunMED 和 First Nation Group 合作,該系統的可用性將擴展到美國各地。這些產品透過刺激組織再生和解決特定傷口類型(例如糖尿病潰瘍或燒傷)來促進更快的傷口癒合。對於治療慢性和不癒合傷口,傳統方法可能效果較差,因此這種方法尤其有價值。
The Japan wound care market size was valued at USD 745.71 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,127.43 Million by 2033, exhibiting a CAGR of 4.30% from 2025-2033. The market is primarily driven by increasing prevalence of chronic conditions like diabetes, advancements in wound care technologies, growing awareness about infection control, rising healthcare spending, government initiatives to improve healthcare infrastructure, and a shift towards minimally invasive treatments, contributing to the market's robust growth.
The market in Japan is majorly driven by the increased incidence of lifestyle diseases, including diabetes and obesity, which has further increased the incidence of chronic wounds, creating a continued need for effective wound management solutions. The aging population in Japan primarily influences the increased prevalence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, consequently increasing demand for advanced wound care products. Further, the improvement of healthcare infrastructure in Japan, along with increased investments in medical technology, makes the market expand. For instance, on August 26, 2024, Japan's Ministry of Health, Labour and Welfare announced its "Global Health Vision 2024," aiming at addressing global health challenges through innovation, equitable access to healthcare, and strengthened international collaboration. This strategy prioritizes pandemic preparedness, health system resilience, and advancing universal health coverage. It strengthens Japan's stance as the leader in global health to serve the United Nations Sustainable Development Goals.
Moreover, increasing awareness among healthcare providers and patients about superior results in advanced wound care products compared to conventional methods further develops market penetration. Apart from that, government-initiated programs aimed at making better health care services available and enhanced reimbursement policies for wound care products promote market growth. Increased focus on research and development (R&D) activities by key industry players increases the rate of new-age product launches aligned to the requirements of the Japanese population, hence also driving the market. For instance, on March 13, 2024, Japanese researchers designed a new age bioelectronic wound dressing, combining hydrogel with microelectronics, to facilitate faster healing with minimal chances of infection. This innovation monitors the wound environment and delivers precise electrical stimulation, enhancing tissue repair. The breakthrough highlights Japan's leadership in merging biotechnology and electronics to address healthcare challenges.
Increased Adoption of Advanced Wound Care Products
The increased adoption of advanced wound care products, such as hydrogels, hydrocolloids, and silver-based dressings, supports the overall Japan wound care market growth. A study published in June 2024 in the Journal of Clinical and Translational Research examined the effectiveness of a new dressing containing silver nanoparticles for chronic ulcers. This advanced dressing heals the wound up to several fold times faster than usual and can offer promising results as a new concept in the chronic management of wounds. Such products offer greater retention of moisture and better antimicrobial action than common wound care products. Therefore, demand for advanced wound care products is expected to rise as Japanese healthcare providers want better results from patients. The desire to minimize healthcare-associated infections and achieve quick healing is motivating to focus on products that offer advanced functionalities like infection control and tissue regeneration.
Growing Role of Telemedicine and Digital Tools
Japan has been investing in digital health technologies, which include telemedicine platforms, mobile health applications, and wound care monitoring systems. These tools enable patients to receive remote consultations, monitor their wound healing process, and gain timely interventions. Healthcare providers can manage several patients through digital platforms efficiently, enhancing accessibility and the continuity of care, especially for patients in rural areas or elderly patients who have mobility problems. This improves patient care in general and optimizes the outcomes of treatments. For example, on June 4, 2024, Infosys and Nihon Chouzai, the biggest dispensing pharmacy chain in Japan, announced a collaboration to enhance healthcare access in Japan through cutting-edge online medication. As a part of this partnership, Infosys designed NiCOMS, a mobile telemedicine application that allows patients to receive remote medication guidance from registered pharmacists, thus not requiring them to visit pharmacies in person.
Rise of Personalized Wound Care Solutions
The rise of personalized wound care solutions, which cater to the individual needs of patients, significantly influences the Japan wound care market share. With advancements in biotechnology and regenerative medicine, products such as bioengineered skin substitutes and negative pressure wound therapy system are gaining popularity. For example, on April 1, 2024, Smith+Nephew, a prominent medical device manufacturer with over 25 years of experience in Japan, launched the RENASYS EDGE Negative Pressure Wound Therapy System for home-based chronic wound care. The compact system is designed for patient comfort and ease of use while ensuring effective treatment. Through partnerships with SunMED and First Nation Group, the system's availability will be expanded across the U.S. These products promote faster wound healing by stimulating tissue regeneration and addressing specific wound types, such as diabetic ulcers or burns. Such options are especially valued in the treatment of chronic and non-healing wounds, where traditional methods may be less effective.
Advanced wound care products, such as hydrocolloids, foams, alginates, and hydrogels are some of the major products that contribute to Japan wound care market. They are preferred for managing chronic and complex wounds as they maintain a moist healing environment, reduce infection risks, and improve healing efficiency. The increasing trend of the geriatric population, along with rising diabetes and venous diseases, will drive demand in Japan for such innovative solutions. Growth in the market is further seen due to advancements in technologies related to negative pressure wound therapy and bioengineered skin substitutes.
Surgical wound care products include sutures, staples, adhesives, and surgical dressings, among others. Being a country that is advanced in terms of medical infrastructure, Japan has a high rate of surgical procedure performance. All these products ensure the proper closure of the wound immediately after surgery. The innovative development of surgical technology, including the use of laparoscopic and robotic procedures, increases demand for specialized wound closure solutions. Investment in antimicrobial and absorbent dressings is further emphasized by the need for infection prevention and quicker recovery, as this aligns with Japan's emphasis on minimizing healthcare-associated complications and enhancing overall care standards.
Traditional wound care products, such as gauze, cotton, and bandages, remain a staple in Japan's wound care market due to their affordability and widespread availability. These products are typically used for minor injuries and home-based care, especially in rural or resource-poor settings. Although the shift towards advanced wound care solutions is increasing, traditional products remain significant in the market. Their cost-effectiveness makes them an attractive choice for basic wound management, especially for less severe cases, ensuring they maintain relevance alongside newer technologies.
Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, represent a significant area of focus in Japan's wound care market due to the aging population. These wounds require advanced therapy with a long time for healing and, therefore, demand NPWT, advanced dressings, and biological products. In addition, the growing prevalence of diabetes and vascular diseases is on the increase and will increase demand for innovative solutions. The emphasis on reducing healthcare expenditure and improving patient outcomes results in better chronic wound management and serves as a rationale for investment in research, new product development, and access to treatments.
Acute wounds resulting from surgical procedures, trauma, or burns are a crucial segment in Japan's wound care market. Acute wounds are associated with high levels of risk and may result in complications if proper treatment is not received on time. It requires treatment through antimicrobial dressings, sutures, staples, and surgical sealants. Due to Japan's advanced development of minimally invasive surgical techniques, there has also been an increase in acute wound products. The country's commitment to high standards of healthcare and the efforts to integrate advanced technologies into wound management practices support the growth of the market.
Hospitals and clinics play a significant role in Japan's wound care market, as they handle complex and acute cases. Hospitals and clinic facilities are well-equipped with diagnostic tools and have highly skilled medical professionals who ensure proper wound management. Most patients with severe injuries, surgical wounds, and chronic conditions such as diabetic ulcers are treated in these facilities. The availability of advanced technology and specialized wound care units in hospitals allows for newer therapy modalities, such as negative pressure wound therapy and bioengineered skin substitutes, to be adopted in growing this market and improving patient outcomes.
Long-term care facilities in Japan are significant for patients with chronic conditions requiring ongoing wound management. Pressure ulcers and diabetic foot ulcers are common among the residents, so prevention and treatment strategies must be effective. These facilities focus on cost-effective wound care products such as hydrocolloid dressings and antimicrobial solutions that bring long-term benefits. Training programs for staff in wound care enhance the quality of services. Long-term care facilities contribute to the changing wound care industry by making specialized goods more in demand as the need for geriatric care keeps growing.
Home care settings assume importance in the wound care market of Japan with the growing need for outpatient and home-based care among the geriatric population. Products like foam dressings, alginate dressings, and portable wound care devices are fast gaining popularity because they are convenient and effective. Home care services minimize hospitalization expenses but allow the patient to return home and enjoy the comfort of their surroundings, enhancing their quality of life. The increased availability of telemedicine also aids this trend by allowing monitoring and guidance remotely by healthcare providers. This shift is in alignment with home-based care policies set by the government and is expected to fuel demand for wound care products in this market segment.
The market in Japan is highly competitive and driven by the advanced healthcare infrastructure, an aging population, and increasing chronic conditions such as diabetes. Companies are focused on innovative solutions such as hydrocolloids, foam dressings, and bioactive products to address complex wounds. The collaboration between healthcare providers, research institutions, and manufacturers drives product development and clinical efficacy. Emerging trends in digital health integration are smart dressings with monitoring capabilities, among others. Strict regulatory standards and the need for cost-effective, high-quality solutions further shape the market. The growth is further supported by increased healthcare spending and expanded wound care education initiatives.
The report provides a comprehensive analysis of the competitive landscape in the Japan wound care market with detailed profiles of all major companies.